Literature DB >> 30539509

Immune-Related Adverse Events: Pneumonitis.

Akash Jain1, Vickie R Shannon1, Ajay Sheshadri2.   

Abstract

Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct patterns. The goal of this chapter is to instruct readers on the incidence and clinical manifestations of pneumonitis and to offer guidance in the evaluation and treatment of patients with pneumonitis.

Entities:  

Keywords:  Checkpoint inhibitors; Diffuse alveolar damage; Hypersensitivity pneumonitis; Immune-related adverse event; Nonspecific interstitial pneumonia; Organizing pneumonia; Pneumonitis; Thoracic imaging

Mesh：

Year:  2018        PMID： 30539509     DOI： 10.1007/978-3-030-02505-2_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  6 in total

1.  Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic.

Authors:  Roberta Fusco; Igino Simonetti; Stefania Ianniello; Alberta Villanacci; Francesca Grassi; Federica Dell'Aversana; Roberta Grassi; Diletta Cozzi; Eleonora Bicci; Pierpaolo Palumbo; Alessandra Borgheresi; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  J Pers Med       Date:  2022-04-12

Review 2.  Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

Authors:  Massimo Ralli; Andrea Botticelli; Irene Claudia Visconti; Diletta Angeletti; Marco Fiore; Paolo Marchetti; Alessandro Lambiase; Marco de Vincentiis; Antonio Greco
Journal:  J Immunol Res       Date:  2020-06-28       Impact factor: 4.818

3.  A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature.

Authors:  Pingping Liu; Yingying Du; Ying Dai; Sha Liu; Yiruo Zhang; Xiaoqiu Li; Zhiyan Zhao
Journal:  J Med Case Rep       Date:  2021-02-01

4.  Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China.

Authors:  Xie Xiaohong; Wang Liqiang; Li Na; Lin Xinqing; Qin Yinyin; Liu Ming; Ouyang Ming; Han Qian; Luo Qun; Li Shiyue; Li Chunyan; Wang Xiaoqian; Yang Shuanying; Huang Wei; Liu Mei; Wang Ping; Zhou Chengzhi
Journal:  Front Mol Biosci       Date:  2021-03-31

Review 5.  Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review.

Authors:  Yujie Yan; Jiamei Fu; Roman O Kowalchuk; Christopher M Wright; Ran Zhang; Xuefei Li; Yaping Xu
Journal:  Transl Lung Cancer Res       Date:  2022-02

6.  Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane.

Authors:  Annelieke E C A B Willemsen; Jolien Tol; Nielka P van Erp; Marianne A Jonker; Maaike de Boer; Bob Meek; Paul C de Jong; Coline van Moorsel; Winald R Gerritsen; Jan C Grutters; Carla M L van Herpen
Journal:  Target Oncol       Date:  2019-08       Impact factor: 4.493
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.